Zone 2 training intensity sweet spot with mitochondria, fat oxidation, and heart brain metabolic longevity benefits
| | |

Zone 2 Training Is the Longevity Exercise Most People Skip: What Mitochondrial Science Reveals About the Intensity Sweet Spot That Protects Your Heart, Brain, and Metabolic Health

New research from 2025 and 2026 confirms that zone 2 training, the low intensity aerobic exercise most people skip, is the single most effective way to build mitochondrial density, improve…

Healthcare Discovery ARPA-H PROSPR program healthspan aging research showing federal clinical trials for healthy longevity
| | |

The U.S. Government Just Made Its Biggest Bet on Healthy Aging: Inside ARPA-H’s $144 Million PROSPR Program

ARPA-H’s $144 million PROSPR program is testing rapamycin, semaglutide, and dapagliflozin in 726 healthy older adults, funding a first-in-humans trial of a retrotransposon-silencing HIV drug, and building a validated biological…

Healthcare Discovery smart money rotating into healthcare AI and precision medicine showing capital flowing from big tech to genomics
| | |

Smart Money Is Rotating Into Healthcare AI: What ARK Invest’s $87M Big Tech Selloff Signals for Precision Medicine

ARK Invest dumped $87 million in Nvidia and Meta last week and redirected capital into Tempus AI, GeneDx Holdings, CRISPR Therapeutics, and other healthcare AI and genomics companies. The signal…

Healthcare Discovery polygenic risk scores heart attack prediction cardiovascular prevention 2026 showing genomic heart risk
| | |

Your DNA Can Now Predict a Heart Attack Decades Before It Happens: How Polygenic Risk Scores Are Rewriting Cardiovascular Prevention

The 2026 ACC/AHA guidelines formally recognize polygenic risk scores as a cardiovascular risk-enhancing factor for the first time. With a multi-ancestry PRS validated across 190,000 participants and the eMERGE Network…